Despite being 'ideal candidates' for weight loss drugs and even offered significant financial incentives, a growing number of women are actively refusing treatment, citing reasons ranging from body identity and medical anxiety to a desire to address the root causes of their weight through natural means.
The article details the phenomenon of 'GLP-1 deniers,' overweight women who, despite medical recommendations and substantial financial offers (like a $7,000 payout to influencer Shaylee Meurer), are refusing to take popular weight-loss drugs. Shaylee Meurer, 5'5" and 240 lbs, turned down numerous offers, stating she's happy with her body and views 'fat' as a descriptor, choosing to honor her body through healthy movement and food after a history of disordered eating and an MS diagnosis. Caitlin Bricker, 5'2" and 193 lbs, experiences significant 'medical anxiety' about being an 'Ozempic guinea pig,' especially after her father developed life-threatening diverticulitis potentially linked to Wegovy. She is actively losing weight through diet and exercise, frustrated by ongoing peer pressure to use GLP-1s. Jalisa Miller, a nurse who once weighed nearly 400 lbs and received a diabetes diagnosis, tried a GLP-1 but stopped due to severe side effects like constipation and headaches. She realized the drug mimicked feelings she wanted to achieve naturally and is now focusing on therapy to address the emotional roots of her eating, combined with fasting, cardio, and weight training. These women share a common experience of intense pressure from doctors, friends, family, and social media to take the drugs, but remain committed to their personal reasons for refusal, emphasizing body autonomy, skepticism about long-term effects, and a belief in tackling underlying issues rather than just symptoms.
